[Research progress on protease-activated receptor 2 in pathogenesis of osteoarthritis]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017 Dec 15;31(12):1517-1522. doi: 10.7507/1002-1892.201705025.
[Article in Chinese]

Abstract

Objective: To review the research progress on protease-activated receptor 2 (PAR-2) in the pathogenesis of osteoarthritis (OA).

Methods: The relevant literature about the mechanism of PAR-2 in the occurrence and development of OA in recent years was extensively reviewed and comprehensively analyzed.

Results: Abnormal activation of PAR-2 plays an important role in responses to occurrence and development of OA. Through regulating production and releasing of a variety of cytokines (such as inflammatory factors, metabolic factors, pain factors, etc.), the PAR-2 can involve in pathophysiological progression of OA articular cartilage, subchondral bone, and synovial membrane, as well as occurrence and transmission of pain.

Conclusion: PAR-2 participation in the development of OA has been confirmed. However, since PAR-2 is complicated and widespread, it is necessary to study the specific role of PAR-2 and the interaction between various signal pathways in the progression of OA, and to elucidate the potential pathophysiological mechanisms of PAR-2 participating in the process of OA, in the hope of exploring the new targets for the effective control of OA.

目的: 综述蛋白酶激活受体 2(protease-activated receptor 2,PAR-2)在骨关节炎(osteoarthritis,OA)发病机制中的研究进展。.

方法: 广泛查阅近年国内外有关 PAR-2 在 OA 发生发展过程中作用机制的文献,并进行综合分析。.

结果: PAR-2 的异常激活在 OA 发生发展过程中发挥重要作用。激活的 PAR-2 可以通过调节炎性因子、代谢因子、致痛因子等的生成及释放,参与 OA 关节软骨、软骨下骨及滑膜的生理和病理变化以及疼痛的产生与传导。.

结论: PAR-2 参与 OA 的发生发展已被证实,但由于 PAR-2 的复杂性以及分布的广泛性,需对其在 OA 进程中的具体作用及各通路间的相互影响进行深入研究,阐明 PAR-2 参与 OA 病变过程的潜在病理生理机制,以期探索新的有效控制 OA 发生的作用靶点。.

Keywords: Osteoarthritis; cytokine; joint; pain; protease-activated receptor 2.

Publication types

  • Review

MeSH terms

  • Cartilage, Articular
  • Cytokines
  • Humans
  • Osteoarthritis / metabolism*
  • Receptor, PAR-2 / physiology*
  • Synovial Membrane

Substances

  • Cytokines
  • Receptor, PAR-2

Grants and funding

国家自然科学基金资助项目(31671235);河北省自然科学基金重点项目(H2016209176);河北省政府资助临床医学优秀人才培养和基础课题研究项目(361036);唐山市科技创新团队培养计划(15130208C);河北省第二批青年拔尖人才支持计划